Period Ending | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 |
---|
Total Revenue
|
7,218,000
|
9,450,000
|
8,640,000
| Cost of Revenue | 591,000 | 953,000 | 1,289,000 | |
Gross Profit
|
-
|
-
|
7,351,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 3,855,000 | 3,826,000 | 3,599,000 |
|
Non Recurring |
-
|
-
| 965,000 |
|
Others | 1,538,000 | 3,543,000 | 4,646,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | |
Operating Income or Loss
|
-
|
-
|
(1,859,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 1,234,000 | 1,128,000 | (1,859,000) |
|
Interest Expense | 294,000 | 361,000 | 805,000 |
|
Income Before Tax | 940,000 | 767,000 | (2,664,000) |
|
Income Tax Expense | 187,000 | 30,000 | (551,000) |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 753,000 | 737,000 | (2,113,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | |
Net Income
|
753,000
|
737,000
|
(2,113,000)
| Preferred Stock And Other Adjustments | (250,000) | (226,000) | (67,000) | |
Net Income Applicable To Common Shares
|
503,000
|
511,000
|
(2,180,000)
|
|